We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.72B
AUM Growth
+$377M
Cap. Flow
-$47.5M
Cap. Flow %
-0.83%
Top 10 Hldgs %
18.31%
Holding
1,615
New
130
Increased
604
Reduced
665
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 19.17%
2 Financials 10.88%
3 Healthcare 10.31%
4 Consumer Discretionary 9.37%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMDV icon
851
ProShares Russell 2000 Dividend Growers ETF
SMDV
$695M
$834K 0.01%
12,477
+1,861
+18% +$121K
LYB icon
852
LyondellBasell Industries
LYB
$20B
$832K 0.01%
9,021
+1,833
+26% +$170K
RHI icon
853
Robert Half
RHI
$3.87B
$832K 0.01%
7,459
-2,337
-24% -$260K
SRVR icon
854
Pacer Data & Infrastructure Real Estate ETF
SRVR
$372M
$830K 0.01%
19,170
+892
+5% +$36.3K
MRSH
855
Marsh
MRSH
$90.5B
$829K 0.01%
4,771
+109
+2% +$18.1K
AVA icon
856
Avista
AVA
$3.34B
$826K 0.01%
+19,453
New +$783K
NRG icon
857
NRG Energy
NRG
$28.3B
$825K 0.01%
19,146
+2,728
+17% +$107K
BLV icon
858
Vanguard Long-Term Bond ETF
BLV
$5.71B
$817K 0.01%
7,936
-917
-10% -$94.8K
FVC icon
859
First Trust Dorsey Wright Dynamic Focus 5 ETF
FVC
$104M
$816K 0.01%
21,573
+1,749
+9% +$65.6K
XLG icon
860
Invesco S&P 500 Top 50 ETF
XLG
$10.6B
$813K 0.01%
22,040
+8,510
+63% +$303K
IR icon
861
Ingersoll Rand
IR
$32.6B
$808K 0.01%
13,053
-198
-1% -$11.3K
IWB icon
862
iShares Russell 1000 ETF
IWB
$48.2B
$807K 0.01%
3,053
-57
-2% -$14.7K
DES icon
863
WisdomTree US SmallCap Dividend Fund
DES
$2.18B
$805K 0.01%
24,489
-40
-0.2% -$1.29K
UTHR icon
864
United Therapeutics
UTHR
$25.8B
$803K 0.01%
3,714
+184
+5% +$36.1K
NCLH icon
865
Norwegian Cruise Line
NCLH
$8.51B
$802K 0.01%
38,636
+1,790
+5% +$42.8K
RSPT icon
866
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.49B
$801K 0.01%
24,710
+500
+2% +$15.5K
JOAN
867
DELISTED
JOANN, Inc. Common Stock
JOAN
$801K 0.01%
77,162
+4,150
+6% +$43.4K
FINX icon
868
Global X FinTech ETF
FINX
$170M
$797K 0.01%
19,901
-4,213
-17% -$200K
MKL icon
869
Markel Group
MKL
$23.3B
$793K 0.01%
643
+159
+33% +$201K
TDG icon
870
TransDigm Group
TDG
$70.2B
$793K 0.01%
1,246
-5,083
-80% -$3.18M
PPH icon
871
VanEck Pharmaceutical ETF
PPH
$959M
$790K 0.01%
10,264
-13
-0.1% -$967
NOVA
872
DELISTED
Sunnova Energy
NOVA
$789K 0.01%
28,250
+200
+0.7% +$7.21K
VAC icon
873
Marriott Vacations Worldwide
VAC
$3.35B
$786K 0.01%
4,651
-14
-0.3% -$2.25K
FCTR icon
874
First Trust Lunt US Factor Rotation ETF
FCTR
$53.6M
$785K 0.01%
22,096
+12,053
+120% +$425K
PCT icon
875
PureCycle Technologies
PCT
$1.28B
$783K 0.01%
81,850
+15,350
+23% +$185K

Similar funds

Oppenheimer & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Oppenheimer & Co held 1,615 positions worth $5.72B, up 7.1% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q4 2021 filing shows 130 new, 604 increased, 665 reduced and 130 closed positions. Its largest new stake was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M. The largest sale was Global X S&P 500 Covered Call ETF, an estimated $49.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q4 2021 buy was Invesco Total Return Bond ETF: 132,838 shares worth $7.49M.
  • Oppenheimer & Co added most to Canadian Pacific Kansas City in Q4 2021, an estimated $7.48M increase.
  • Oppenheimer & Co's biggest Q4 2021 reduction was Global X S&P 500 Covered Call ETF, cutting an estimated $49.9M.
  • Oppenheimer & Co fully exited Kansas City Southern in Q4 2021, selling an estimated $6.61M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.72B portfolio in Q4 2021.
  • Oppenheimer & Co opened 130 new positions and closed 130 in Q4 2021.
  • Oppenheimer & Co's portfolio value rose 7.1% quarter-over-quarter to $5.72B.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.